Establishes and maintains relationships with healthcare entities, serving as an educational and informational resource.
Delivers fair-balanced clinical and scientific presentations to healthcare professionals and patient organizations.
Collaborates across multi-disciplinary internal groups to support medical/scientific and business objectives.
Shionogi Inc. is a pharmaceutical company that supports and represents its products with key opinion leaders, clinicians, institutions, and professional organizations. They focus on building long-term relationships and establishing rapport with healthcare professionals through scientific disease state and product discussions.
Develop and enhance professional relationships with medical thought leaders within the metabolic and oncologic space.
Provide medical information through scientific exchange, and clinical/scientific support for Rezolute and the Medical Affairs department.
Identify and communicate key clinical and research issues and insights from KOLs to appropriate departments.
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). They have an antibody therapy, RZ358 (ersodetug), designed to treat all forms of HI and has shown substantial benefit in clinical trials.
Develop and maintain relationships with healthcare professionals and key stakeholders.
Serve as the primary source of balanced medical and scientific information.
Lead cross-functional collaborations and mentor peer MSLs.
BridgeBio pools early-stage research from academia to reduce risk and unleash innovation, focusing on rare diseases and developing life-changing medicines. They value curiosity and experimentation, encouraging employees to challenge conventions and reengineer the future of biopharma.
Engage, educate, and support Galleri ordering providers and cancer diagnostic specialists, oncologists, Key Opinion Leaders (KOLs), and Health Care System (HCS) influencers.
Maintain in-depth clinical, scientific, and technical expertise related to GRAIL’s products, cancer screening, and cancer diagnostic guidelines through continuous learning.
Summarize and communicate complex medical messages to enable clear and concise understanding by both external audiences and partners within GRAIL
GRAIL is dedicated to detecting cancer early, striving to change the trajectory of cancer mortality. They have a multi-disciplinary organization of scientists, engineers, and physicians and they are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science.
Recruit, onboard, train, and develop MSL talent to build a culture of excellence and accountability.
Oversee regional KOL mapping, segmentation, and engagement plans aligned with national medical strategy.
Guide regional execution of scientific engagement at national and regional psychiatry conferences, advisory boards, and educational events.
Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Founded in 2019, they are continuously expanding their presence and global footprint and searching for high-impact individuals to strengthen their team of patient-centric individuals.
Supports research initiatives across development at the request of R&D.
Identifies, gains access to, and develops professional relationships with external experts (EEs).
Provides education relative to disease state and AbbVie products across the product lifecycle to healthcare providers and researchers.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. They strive to have a remarkable impact on people's lives across several key therapeutic areas.
Primary point of contact for HCPs and stakeholders, an ambassador.
Build business account strategies with practical insight from the field.
Achieve sales target and KPI’s through development of local account plans.
Kyowa Kirin International (KKI)'s purpose is to make people smile. They are an inclusive pharmaceutical company that takes time to understand what really matters to our patients, their families, and their healthcare professionals, helping people to take bold actions that deliver life-changing solutions sooner.
Play a pivotal role in shaping and executing an integrated scientific communications strategy.
Lead medical education initiatives, publication strategy, and support of the Brain Health Collaboratories.
Translate complex preclinical, clinical, and real-world data into clear, accurate, and compliant communications.
Cognito Therapeutics, Inc. is translating scientific findings from MIT into therapeutic approaches for brain health, including Alzheimer’s disease and other neurodegenerative conditions. They are a fast-moving, highly motivated team of innovators with the ambitious goal of helping millions of patients and caregivers around the world.
Provide scientific and/or clinical presentations on Natera’s Organ Health division focused on kidney transplant (Prospera) and renal genetic testing (Renasight) products.
Address the specific needs of customers by responding to requests for information about our marketed and developing products.
Serve as a medical and scientific resource for the Natera Sales and Marketing teams.
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. They aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions.
Own and lead the development and execution of national account medical strategies.
Serve as the primary medical/scientific partner to ALDS.
Partner closely with AMI, Commercial and R&D to ensure streamlined communication.
AbbVie discovers and delivers innovative medicines and solutions that solve serious health issues today and addresses the medical challenges of tomorrow. With a focus on immunology, oncology, neuroscience, and aesthetics, they strive to have a remarkable impact on people's lives.
Leading and motivating teams to deliver communications programmes.
Arc Bio Communications delivers global communications strategies for biopharmaceutical and biotechnology companies that add value and bring innovations to life. In 2024, it joined forces with IQVIA to expand global capabilities and influence.